Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Join the Next Science Investor Hub to interact with our announcements and updates, have your questions answered, and receive ASX Announcements and Company Updates to your inbox. Click here to sign up to the Next Science Investor Hub.

Reporting Calendar

Reporting date Details of report
31 October 2023 Quarterly Report
31 August 2023 Half-Yearly Report
31 July 2023 Quarterly Report
26 May 2023 FY22 AGM Chair & Managing Director Address
30 April 2023 Annual Report / Quarterly Report
28 February 2023 Preliminary Final Report
2 February 2023 General Meeting
30 January 2023 Quarterly Report

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474